Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials

(2014) Salvatore Cassese et al.   ATHEROSCLEROSIS

The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report—2014; Focus Theme: Retransplantation

(2014) Lars H. Lund et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES)

(2013) F. Ribichini et al.   EUROPEAN HEART JOURNAL

Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease

(2013) George D. Dangas et al.   JACC-Cardiovascular Interventions

5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents

(2013) Hemal Gada et al.   JACC-Cardiovascular Interventions

Cardiac Allograft Vasculopathy by Intravascular Ultrasound in Heart Transplant Patients

(2013) Jon A. Kobashigawa et al.   JACC-Heart Failure

Third Universal Definition of Myocardial Infarction

(2012) Kristian Thygesen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Drug-Eluting Versus Bare Metal Stents in Cardiac Allograft Vasculopathy

(2011) Jennifer A. Tremmel et al.   AMERICAN JOURNAL OF CARDIOLOGY

Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: Three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial

(2011) Alfredo E. Rodriguez et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Drug eluting versus bare metal stents in cardiac allograft vasculopathy

(2011) Tarun W. Dasari et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease

(2011) Michael S. Lee et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Sirolimus as Primary Immunosuppression Attenuates Allograft Vasculopathy With Improved Late Survival and Decreased Cardiac Events After Cardiac Transplantation

(2011) Yan Topilsky et al.   CIRCULATION

Contemporary Clinical Applications of Coronary Intravascular Ultrasound

(2011) Michael C. McDaniel et al.   JACC-Cardiovascular Interventions

Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

(2011) Kyung Woo Park et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

(2011) Glenn N. Levine et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy

(2009) Tonga Nfor et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery disease

(2009) Farzin Beygui et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy

(2008) Michael S. Lee et al.   JACC-Cardiovascular Interventions

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

(2008) Gregg W. Stone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Outcomes of Bare Metal versus Drug-eluting Stents in Allograft Vasculopathy

(2008) Proddutur R. Reddy et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION